Related Experiment Video
Updated: Jun 12, 2026
10:07
High-throughput Screening for Small-molecule Modulators of Inward Rectifier Potassium Channels
Published on: January 27, 2013
Inhibitory action of fluvoxamine on Kv1.5 currents
Hyang Mi Lee1, Sang June Hahn, Bok Hee Choi
1Department of Pharmacology, Institute for Medical Sciences, Chonbuk National University Medical School, Jeonbuk 561-180, Republic of Korea.
Biological & Pharmaceutical Bulletin
|June 5, 2010
Summary
Fluvoxamine reversibly inhibits the Kv1.5 potassium channel in a concentration-dependent manner. This drug interaction affects channel gating and is state-dependent, suggesting a mixed inhibition mechanism.
Area of Science:
- Pharmacology
- Molecular Biology
- Electrophysiology
Background:
- Voltage-gated potassium channels, specifically Kv1.5, play crucial roles in cellular electrical activity.
- Fluvoxamine, a selective serotonin reuptake inhibitor, has potential off-target effects on ion channels.
Purpose of the Study:
- To investigate the interaction between the potassium channel Kv1.5 and the drug fluvoxamine.
- To characterize the inhibitory effects of fluvoxamine on Kv1.5 channel function.
Main Methods:
- Whole-cell patch-clamp technique was employed to record Kv1.5 currents in Chinese hamster ovary cells.
- Concentration-response relationships and voltage-dependence of inhibition were analyzed.
Main Results:
- Fluvoxamine inhibited Kv1.5 currents reversibly and in a concentration-dependent manner (IC50 = 2.0 microM).
- Inhibition was time-dependent, state-dependent (affecting closed/resting states), and use-dependent.
- Fluvoxamine altered channel gating kinetics, slowing deactivation and causing a tail crossover phenomenon.
Conclusions:
- Fluvoxamine strongly inhibits Kv1.5 channel currents.
- The inhibition mechanism is mixed and channel-state dependent, indicating complex interactions with the Kv1.5 channel.
More Related Videos
Related Concept Videos
01:28Depolarizing Blockers: Mechanism of Action
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
01:20Antiepileptic Drugs: Potassium Channel Activators
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
01:26Voltage-gated Ion Channels
Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
01:26Voltage-gated Ion Channels
Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...